Pharmacy Benefit Management

CVS Health Corp. is experimenting with indication-based pricing as part of its new Transform Rheumatoid Arthritis Care program, which could help enrollees see savings as high as 5% on their annual spend for RA drugs. PBMs say indication-based pricing, in which medications are priced differently depending on their effectiveness in different indications, works for the anti-inflammatory class due to its high cost and growing availability of biosimilars. Autoimmune drugs are some of the most expensive therapeutic treatments, reaching several thousands of dollars per month. Read more

From Radar on Drug Benefits - A year after the first follow-on biologic Basaglar (insulin glargine) from Eli Lilly and Co. and Boehringer Ingelheim Pharmaceuticals, Inc. launched in the U.S. diabetes market, access to the drug among payers is growing rapidly, with half of all U.S. formularies placing it on their first or second tier. Read more

It's quick and easy to sign up for FREE access to!

Why do I need to register?

Resources for Paid Subscribers
Not a Paid Subscriber?

Check out all of the benefits, sample issues & more!